Privia Health Group (NASDAQ:PRVA) today announced fiscal year 2025 results that landed at or above the high end of its previously issued guidance, bolstered by strong provider implementation and a disciplined focus on value-based care.
The physician-enablement company posted total revenue of $2,122.8 million, representing a 22.3% increase over the prior year.
The company's profitability saw even sharper gains, with net income rising 59.3% to $22.9 million.
Adjusted EBITDA grew 38.8% year-over-year to $125.5 million, reflecting the scalability of Privia’s technology platform and clinical network as it expands across new and existing markets.
Privia Health enters 2026 with a robust balance sheet, ending the year with $479.7 million in cash and equivalents and maintaining a position with no debt.
Cash flow from operating activities was equally strong, climbing 49.5% to $163.4 million, providing the company with significant capital to fund organic growth and potential strategic initiatives.
Meanwhile, management issued a confident outlook for the 2026 fiscal year, highlighting the durability of its business model.